PRESS RELEASE published on 01/16/2024 at 12:30, 2 years 1 month ago ASCEND’s Telepresence Technology, Catalyst LIVE, Transforms Diagnostic Imaging ASCEND Cardiovascular introduces Catalyst LIVE, a groundbreaking IoT device that revolutionizes real-time collaboration between diagnosticians and procedural teams. This cutting-edge technology improves workflow and empowers medical specialists to make better-informed and quicker care decisions for patients undergoing imaging procedures. With Catalyst LIVE, ASCEND Cardiovascular is at the forefront of pioneering healthcare solutions, reaffirming its commitment to innovation and patient-centric care. Healthcare Solutions ASCEND Cardiovascular Catalyst LIVE IoT Device Patient-centric Care
Published on 02/20/2026 at 18:30, 12 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 2 hours 57 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 12 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 34 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 42 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 5 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 10 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 41 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 41 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 9 hours 14 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 14 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026